These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16170487)

  • 1. [Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)].
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Alberti W
    Strahlenther Onkol; 2005 Sep; 181(9):595-600. PubMed ID: 16170487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal reirradiation after short-course RT for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Veninga T; Hoskin PJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):872-5. PubMed ID: 15939549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
    Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE
    Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
    J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.
    Rades D; Walz J; Stalpers LJ; Veninga T; Schulte R; Obralic N; Wildfang I; Engenhart-Cabilic R; Hoskin PJ; Schild SE
    Eur Urol; 2006 May; 49(5):846-52; discussion 852. PubMed ID: 16442206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.
    Rades D; Fehlauer F; Stalpers LJ; Wildfang I; Zschenker O; Schild SE; Schmoll HJ; Karstens JH; Alberti W
    Cancer; 2004 Dec; 101(11):2687-92. PubMed ID: 15493037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and toxicity of single-fraction radiotherapy with 1 x 8 Gy for metastatic spinal cord compression.
    Rades D; Stalpers LJ; Hulshof MC; Zschenker O; Alberti W; Koning CC
    Radiother Oncol; 2005 Apr; 75(1):70-3. PubMed ID: 15878103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
    Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial.
    Maranzano E; Bellavita R; Rossi R; De Angelis V; Frattegiani A; Bagnoli R; Mignogna M; Beneventi S; Lupattelli M; Ponticelli P; Biti GP; Latini P
    J Clin Oncol; 2005 May; 23(15):3358-65. PubMed ID: 15738534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.
    Rades D; Stalpers LJ; Veninga T; Rudat V; Schulte R; Hoskin PJ
    J Urol; 2006 Feb; 175(2):552-6. PubMed ID: 16406994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients.
    Rades D; Stalpers LJ; Schulte R; Veninga T; Basic H; Engenhart-Cabilic R; Schild SE; Hoskin PJ
    Eur J Cancer; 2006 May; 42(8):1052-6. PubMed ID: 16580192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?
    Rades D; Walz J; Schild SE; Veninga T; Dunst J
    Urology; 2007 Jun; 69(6):1081-5. PubMed ID: 17572191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
    Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
    Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial.
    Maranzano E; Trippa F; Casale M; Costantini S; Lupattelli M; Bellavita R; Marafioti L; Pergolizzi S; Santacaterina A; Mignogna M; Silvano G; Fusco V
    Radiother Oncol; 2009 Nov; 93(2):174-9. PubMed ID: 19520448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Rades D; Dahm-Daphi J; Rudat V; Schulte R; Stalpers LJ; Veninga T; Hoskin PJ
    Strahlenther Onkol; 2006 Dec; 182(12):708-12. PubMed ID: 17149577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression.
    Rades D; Stalpers LJ; Hulshof MC; Borgmann K; Karstens JH; Koning CC; Alberti W
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):514-8. PubMed ID: 15890595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
    Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
    J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
    Rades D; Hoskin PJ; Stalpers LJ; Schulte R; Poortmans P; Veninga T; Dahm-Daphi J; Obralic N; Wildfang I; Bahrehmand R; Engenhart-Cabilic R; Schild SE
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1452-7. PubMed ID: 16413695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
    Rades D; Rudat V; Veninga T; Stalpers LJ; Basic H; Karstens JH; Hoskin PJ; Schild SE
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):905-8. PubMed ID: 18436390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.